Clinical Trial Update: An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 study completed evaluating Palonosetron for efficacy and safety in preventing chemotherapy-induced nausea and vomiting in Chinese cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aloxi (palonosetron hydrochloride)

Snippet

Sponsor: Xijing Hospital | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 2 | Status: COMPLETED